prothymosin alpha comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-31. Numbers and descriptions here follow the published literature rather than marketing material.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.
Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.
Practical handling focuses on limiting adsorption and contamination. The peptide dissolves readily in water, and dilute solutions tend to adhere to plastic and glass surfaces, so an inert carrier protein or a defined buffer can reduce losses in laboratory work. Workers also record the counter-ion form, since an acetate or trifluoroacetate salt changes the mass balance of the weighed powder. Documentation of lot number, purity value, and storage history supports reproducibility when results from different laboratories are compared.
=== Mid-20th century === Public events in Bryant Park were held through the mid-20th century. For instance, in 1944 during World War II, an aircraft demonstration was held in the park. Outdoor summer concerts in Bryant Park were started in 1948 by Philip Lieson Miller, a musicologist at the New York Public Library. These concerts took place from 12 to 2 p.m. on weekdays from July through September. On October 15, 1969, forty thousand people attended a rally in Bryant Park as part of the nationwide Moratorium to End the War in Vietnam. Another large event, the Big Apple Circus, was proposed to be held in Bryant Park in 1978, but parks commissioner Gordon Davis denied the circus permission to host a show there, since it would have closed off Bryant Park to the public. Plans to build parking garages under Bryant Park also surfaced in the mid-20th century, as a means of relieving parking shortages in Midtown Manhattan. The first such plan was made in 1946 when the city conducted a survey to determine the feasibility of such a garage. Parks commissioner Moses opposed the plan. A parking garage was proposed again in 1958, with plans for 1,200 spaces, though Moses also opposed this proposal. This proposal was backed by the Avenue of the Americas Association. However, though Mayor Robert F. Wagner Jr. supported the proposal, the New York City Planning Commission voted against it in November 1961.
=== From conventional antibodies === Alternatively, single-domain antibodies can be made from common murine, rabbit or human IgG with four chains. The process is similar, comprising gene libraries from immunized or naïve donors and display techniques for identification of the most specific antigens. A problem with this approach is that the binding region of common IgG consists of two domains (VH and VL), which tend to dimerize or aggregate because of their lipophilicity. Monomerization is usually accomplished by replacing lipophilic by hydrophilic amino acids, but often results in a loss of affinity to the antigen. If affinity can be retained, the single-domain antibodies can likewise be produced in E. coli, S. cerevisiae or other organisms.
Psilocybe cubensis grows naturally in tropical and subtropical conditions, often near cattle due to the ideal conditions they provide for the growth of the fungus. The cow usually consumes grains or grass covered with the spores of P. cubensis and the fungus will begin to germinate within the dung. Mushrooms such as Psilocybe cubensis are relatively easy to cultivate indoors. First, spores are inoculated within sterilized jars or bags, colloquially known as grainspawn, containing a form of carbohydrate nutrient such as rye or milo gains. After approximately one month, the spores fully colonize the grain spawn forming dense mycelium, which is then mixed within a bulk substrate such as a coconut husk fiber and vermiculite mixture. Given proper humidity, temperature, and fresh air exchange, the substrate will produce fruiting Psilocybe cubensis bodies within a month of planting. To preserve potency after harvesting, growers often dehydrate the fruit and store them in air-tight containers in cool environments. A study conducted in 2009 showed that mushrooms grown in the dark had higher levels of psilocybin and psilocin compared to the mushrooms grown in bright, indirect light, which had minimum levels. Studies were conducted where an environmentally controlled wind tunnel and a computer program were used to determine the influence of humidity on the individual basidiocarps of P. cubensis which aided in mapping their growth and development.
Sources: en.wikipedia.org
The US Department of Defense reports that US forces suffered 148 battle-related deaths, 35 to friendly fire. One pilot was listed as MIA. His remains were found and identified in August 2009. A further 145 Americans died in non-combat accidents. The UK suffered 47 deaths (nine to friendly fire, all by US forces), France nine. The other coalition countries, not including Kuwait, suffered 37 deaths (18 Saudis, one Egyptian, six UAE and three Qataris). At least 605 Kuwaiti soldiers were still missing 10 years after their capture. The largest single loss of life among coalition forces happened on 25 February 1991, when an Iraqi Al Hussein missile hit a US military barrack in Dhahran, Saudi Arabia, killing 28 US Army Reservists from Pennsylvania. In all, 190 coalition troops were killed by Iraqi fire during the war, 113 of whom were American, out of 358 coalition deaths. Another 44 soldiers were killed and 57 wounded by friendly fire. 145 soldiers died of exploding munitions or non-combat accidents. The largest accident among coalition forces happened on 21 March 1991, when a Royal Saudi Air Force C-130H crashed in heavy smoke on approach to Ras Al-Mishab Airport, Saudi Arabia. 92 Senegalese soldiers and six Saudi crew members were killed. The number of coalition wounded in combat was 776, including 458 Americans. 190 coalition troops were killed by Iraqi combatants, the rest of the 379 coalition deaths were from friendly fire or accidents. This number was much lower than expected. Among the American combat dead were four female soldiers.
=== Neurodegeneration and chronic pain === Big dynorphin is upregulated in spinal cord injury and chronic pain states, where excessive big dynorphin production through both opioid and non-opioid receptor mechanisms contribute to neuronal death, neuroinflammation, and pain chronification.
== Sources == This article incorporates text from a free content work. Licensed under CC BY 4.0. Text taken from The State of Food Security and Nutrition in the World 2024, FAO, IFAD, UNICEF, WFP and WHO, FAO. This article incorporates text from a free content work. Licensed under CC BY 4.0 (license statement/permission). Text taken from The State of Food Security and Nutrition in the World 2026, Food and Agriculture Organization of the United Nations.
Research on PFOA has demonstrated ubiquity, animal-based toxicity, and some associations with human health parameters and potential health effects. Additionally, advances in analytical chemistry in recent years have allowed the routine detection of low- and sub-parts per billion levels of PFOA in a variety of substances. In 2013, Gore-Tex eliminated the use of PFOAs in the manufacture of its weatherproof functional fabrics. Major companies producing PFOA signed with the Global PFOA Stewardship Program with the goal of elimination of PFOA by 2015. Since then it has been eliminated from the production of non-stick materials used in cookware. GenX has been introduced as a replacement for PFOA, but in a 2015 study which tested the effects on rats, GenX caused many of the same health problems as PFOA, but required much higher concentrations. This is because GenX (C3) is a short chain alternative to PFOA. GenX also has a significantly shorter half-life than PFOA so it is not as bio-persistent as PFOA or other long chain perfluorinated chemicals.
Sources: en.wikipedia.org
===== UPMC Lemieux Sports Complex ===== The UPMC Lemieux Sports Complex, opened in 2015 in Cranberry Township, is a 185,000 square feet (17,200 m2) contains both a comprehensive outpatient facility for UPMC Sports Medicine and the primary training facilities for the NHL's Pittsburgh Penguins, and the secondary venue for their ECHL affiliate, the Wheeling Nailers. The outpatient clinic includes orthopedic, primary care, physical therapy, concussion, imaging, and sports performance services. The training facility includes two-full-sized ice rinks, training and locker rooms, video review facility, and executive offices.
Opioid effects (adverse or otherwise) can be reversed with an opioid antagonist such as naloxone or naltrexone. These competitive antagonists bind to the opioid receptors with higher affinity than agonists but do not activate the receptors. This displaces the agonist, attenuating or reversing the agonist effects. However, the elimination half-life of naloxone can be shorter than that of the opioid itself, so repeat dosing or continuous infusion may be required, or a longer acting antagonist such as nalmefene may be used. In patients taking opioids regularly who receive opioid antagonists under medical supervision, it is essential that the opioid is only partially reversed to avoid a severe and distressing reaction of waking in excruciating pain. This is achieved by not giving a full dose but giving this in small doses until the respiratory rate has improved. An infusion is then started to keep the reversal at that level, while maintaining pain relief. Opioid antagonists remain the standard treatment for respiratory depression following opioid overdose, with naloxone being by far the most commonly used, although the longer acting antagonist nalmefene may be used for treating overdoses of long-acting opioids such as methadone, and diprenorphine is used for reversing the effects of extremely potent opioids used in veterinary medicine such as etorphine and carfentanil.
== Etymology == The historical origin of the term is unclear as the definition of the word has changed throughout the past few decades. The term first appeared in a 1984 publication that described the organization of an endothelium-like membrane on the surface of a long-implanted, synthetic ophthalmic prosthesis. The first modern use of the term as recognized today was in 1985 by the researcher, physiologist and bioengineer Yuan-Cheng Fung of the Engineering Research Center. He proposed the joining of the terms tissue (in reference to the fundamental relationship between cells and organs) and engineering (in reference to the field of modification of said tissues). The term was officially adopted in 1987.
=== Effects on antigenicity of milk proteins === A study in 2012 posed the question of whether or not Lactobacillus delbrueckii subsp. bulgaricus had any effect on the antigenicity of four kinds of milk proteins, being α-lactalbumin (α-LA), β-lactoglobulin (β-LG), α-casein (α-CN), and β-casein (β-CN). These proteins are the main proteins found in cow's milk and are known to have antigenic properties in humans, especially young children and infants. 2–5% of young children and infants experience cow's milk protein allergy (CMPA), which has harmful effects on their development and may even result in death. This allergy is facilitated through the antigenicity of the milk proteins, which is the ability of the proteins to trigger an immune response in the body that can result in a number of possible allergic reactions. The study was performed by simulating digestion of unfermented milk and milk that was fermented through exposure to Lactobacillus delbrueckii subsp. bulgaricus to compare their antigenicities in order to see if fermentation had any effect on the antigenicity of the proteins. The antigenicities were measured through an enzyme-linked immunosorbent assay (ELISA). The results claimed that the fermentation of cow's milk by Lactobacillus delbrueckii subsp. bulgaricus reduced the antigenicity of α-LA and β-CN. However, it also increased the antigenicity of α-CN while β-LG was not impacted.
Between 1979 and 1980, the pace of infiltration had accelerated so greatly that the SADF was forced to mobilise its reserves and deploy another 8,000 troops to South West Africa. The deeper South African raids struck into Angola, the more the war spread, and by mid-1980 the fighting had extended to a much larger geographic area than before. Operation Sceptic, then the largest combined arms offensive undertaken by South Africa since World War II, was launched in June against a PLAN base at Chifufua, over a hundred and eighty kilometres inside Angola. Chifufua, codenamed Objective Smokeshell, was divided into a dozen well fortified complexes ringed with trenches, defensive bunkers, and anti-aircraft positions. The SADF killed over 200 insurgents and captured several hundred tonnes of PLAN munitions and weaponry at the cost of 17 dead. Operation Protea was mounted on an even larger scale and inflicted heavier PLAN casualties; unlike Sceptic, it was to involve significant FAPLA losses as well as the seizure of substantial amounts of Angolan military hardware and supplies. Protea was planned when the SADF first became aware of PLAN's evolving conventional capabilities in August 1981. Its targets were suspected PLAN bases sited outside major FAPLA installations at Ondjiva and Xangongo. Attacking either settlement was considered especially risky due to the presence of Soviet advisers and a comprehensive local FAPLA air defence network.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.